Loading…
peptidesIn Stock
Retatrutide 20mg
Triple agonist for advanced metabolic research
£49.95
99.3% purity1
Certificate of Analysis available
This batch has been independently tested at 99.3% purity. View the COA in the image gallery.
Retatrutide is a novel triple agonist targeting GIP, GLP-1, and glucagon receptors. Cutting-edge research compound for investigating multi-pathway metabolic regulation and energy expenditure.
For in-vitro research use only. This product is not intended for human consumption, medical, veterinary, or household use. By purchasing, you confirm you are a qualified researcher.
